Skip to main content
SpringerLink
Log in

Chronic HBV Carrier’s acceptance of regular surveilling program in China

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

Long-term compliance with regular surveillance is important for the prevention and timely management of chronic hepatitis B (CHB). However, there are no researches focusing on the compliance of hepatitis B virus infected patients in regular surveillance so far. The purpose of our study was to investigate the outpatient compliance with long-term regular surveillance in China. Data of 3257 CHB outpatients was pooled and analyzed to assess the outpatient’s compliance with the long-term regular surveillance plan. In all outpatients, the non-follow-up and the follow-up group accounted for 73.2% and 26.8%, respectively. Among the follow-up outpatient’s, only 48.9% received ongoing-follow-up and 51.1% were finally lost to follow-up; the median length of visiting duration was 25 months; and the predictive 1-, 2-, 3-, 4- and 5-year ongoing follow-up rate was 72.7%, 52.5%, 42.4%, 33.8%, and 26.3%, respectively. In conclusion, our survey proved that the regular long-term surveillance on Chinese chronic HBV carrier is difficult to be fully implemented. A large proportion of outpatients do not receive routine follow-up and are at risk of treatment delay due to various social reasons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med, 2004,350(11):1118–1129

    Article  PubMed  CAS  Google Scholar 

  2. Liu J, Fan DM. Hepatitis B in China. Lancet, 2007,369(9573):1582–1583

    Article  PubMed  Google Scholar 

  3. Liang XF, Chen YS, Wang XJ, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old: the report from Chinese Center for Disease Control and Prevention. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2005,26(9):655–658

    Google Scholar 

  4. Cui FQ, Wang XJ, Liang XF. Epidemiological analysis on reported hepatitis B under 15 years in China: the report from Chinese Center for Disease Control and Prevention. Zhongguo Yi miao He Mianyi Za Zhi (Chinese), 2006,12(3):206–208

    Google Scholar 

  5. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross sectional study of Asians in California. Hepatology, 2007,46(4):1034–1040

    Article  PubMed  Google Scholar 

  6. Wai CT, Mak B, Chua W, et al. The majority of hepatitis B carriers are not on regular surveillance in Singapore. Singapore Med J, 2004,45(9):423–426

    PubMed  CAS  Google Scholar 

  7. Lok AS. The maze of treatments for hepatitis B. N Engl J Med, 2005,352(26):2743–2746

    Article  PubMed  CAS  Google Scholar 

  8. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med, 2005,352(26):2673–2681

    Article  PubMed  CAS  Google Scholar 

  9. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study. Hepatology, 2000,32(4 Pt 1):842–846

    Article  PubMed  CAS  Google Scholar 

  10. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Zhongguo Bing Du Xue Za Zhi (Chinese), 2011,1(1):9–22

    Google Scholar 

  11. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology, 2009,50(3):661–662

    Article  PubMed  Google Scholar 

  12. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B. J Hepatol, 2009,50(2):227–242

    Article  Google Scholar 

  13. Liaw YF, Leung N, Kao JH, et al. Asian-Pacific Consensus Statement on the Management of Chronic Hepatitis B: a 2008 Update. Hepatol Int, 2008,2(3):263–283

    Article  PubMed  Google Scholar 

  14. Sherman M, Shafran S, Burak K, et al. CANADIAN CONSENSUS GUIDELINES Management of chronic hepatitis B: Consensus guidelines. Can J Gastroenterol, 2007,21(Suppl C):5–24

    Google Scholar 

  15. Veldhuijzen IK, Toy M, Hahne SKM, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology, 2006,138(2):522–530

    Article  Google Scholar 

  16. Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach. Gastroenterology, 2008,134(2):405–415

    Article  PubMed  Google Scholar 

  17. Giannini EG, Torre F, Basso M, et al. A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy. J Clin Gastroenterol, 2009,43(10):1001–1007

    Article  PubMed  Google Scholar 

  18. Jung CW, Tan J, Tan N, et al. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population. J Gastroenterol Hepatol, 2010,25(2):369–375

    Article  PubMed  Google Scholar 

  19. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat, 2011,18(6):377–383

    Article  PubMed  CAS  Google Scholar 

  20. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl), 2009,122(1):3–4

    Google Scholar 

  21. Fang Q, Hao YH, Li L, et al. Primary construction of the electronic medical records for patients with liver diseases. Yi Xue Yu She Hui (Chinese), 2012,25(4):29–31

    Google Scholar 

  22. Fang Q, Li L, Zhang ZH, et al. Analysis of the constituent ratio and its clinical diagnostic subtypes for patients with chronic HBsAg infection in their first outpatient visit. Nei Ke Ji Wei Zhong Zhen Yi Xue Za Zhi (Chinese), 2012,18(2):98–101

    Google Scholar 

  23. Chao J, Chang ET, So SKS. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health, 2010,10:98

    Article  PubMed  Google Scholar 

  24. Blumenthal D, Hsiao W. Privatization and its discontents—the evolving Chinese health care system. N Engl J Med, 2005,353(11):1165–1170

    Article  PubMed  CAS  Google Scholar 

  25. Dong N, He B, Zhuang H. An online questionnaire survey on awareness of antiviral treatment in patients with chronic hepatitis B. Chin Hepatol, 2009,14(1):8–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Devivision of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Qing Fang  (方 清), You-hua Hao  (郝友华), Lei Li  (李 磊), Zhen-hua Zhang  (张振华), Jun-zhong Wang  (王俊忠), Ming-fa Chen  (陈明发), Jian Kang  (康 健) & Dong-liang Yang  (杨东亮)

  2. Department of Infectious Diseases, the First College of Clinical Medical Sciences, China Three Gorges University & Yichang Central People’s Hospital, Yichang, 443003, China

    Qing Fang  (方 清)

  3. Department of Infections Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Dong-liang Yang  (杨东亮)

Authors
  1. Qing Fang  (方 清)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. You-hua Hao  (郝友华)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lei Li  (李 磊)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhen-hua Zhang  (张振华)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun-zhong Wang  (王俊忠)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ming-fa Chen  (陈明发)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian Kang  (康 健)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dong-liang Yang  (杨东亮)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong-liang Yang  (杨东亮).

Additional information

This project was supported by grants from the National Mega Research Program of China (No. 2008ZX10002-011), the National Key Basic Research Program of China (No. 2005CB 522901, 2007CB512804, 2009CB522500), the National Natural Science Foundation of China (No. 30571646) and Deutsche Forschungsgemeinschaft (TRR60) to Dong-liang YANG.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fang, Q., Hao, Yh., Li, L. et al. Chronic HBV Carrier’s acceptance of regular surveilling program in China. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 33, 288–292 (2013). https://doi.org/10.1007/s11596-013-1113-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-013-1113-z

Key words

Search

Navigation